What is the recommended treatment for a full‑thickness chondral fissure of the knee?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Full-Thickness Chondral Fissure of the Knee

Microfracture is the recommended first-line treatment for full-thickness chondral fissures of the knee when the lesion is focal, contained, and less than 4 cm² in patients with minimal osteoarthritis. 1, 2

Patient Selection Criteria

Before proceeding with any joint-preserving intervention, verify the patient meets these specific criteria 2:

  • Age: Skeletal maturity to 50 years
  • Osteoarthritis status: Minimal or no signs (Tönnis grade ≤1) 1
  • Lesion characteristics: Full-thickness defect without bipolar involvement
  • Functional capacity: Ability to perform rigorous postoperative physical therapy
  • Inflammatory status: No inflammatory arthritis present

Treatment Algorithm Based on Lesion Size

Lesions <2 cm²

Microfracture is the definitive first-line treatment 1, 2. This technique achieves a mean 93% ± 17% defect fill with good-quality cartilage macroscopically at second-look arthroscopy 3, 1.

Lesions 2-6 cm²

  • Femoral condyle/trochlear lesions: Microfracture remains first-line 1
  • Femoral head lesions: Consider mosaicplasty or single-plug osteochondral allograft 1
  • Acetabular lesions: Microfracture is preferred 1

Lesions >6 cm²

Conversion to total knee arthroplasty should be considered in appropriate candidates 1.

Microfracture Surgical Technique

The procedure follows this specific sequence 3:

  1. Debridement phase: Remove all friable cartilage using a shaver
  2. Edge preparation: Use ringed curets to create a well-contained lesion with perpendicular edges of healthy, well-attached cartilage
  3. Awl placement: Create 3-4 mm deep perpendicular holes in subchondral bone, spaced 3-4 mm apart to preserve subchondral bone bridges between holes
  4. Endpoint: Continue until bleeding is visualized from the marrow spaces

The mechanism works by releasing pluripotent marrow cells and growth factors from underlying bone marrow, which form fibrocartilage to fill the defect 3.

Expected Outcomes

Clinical improvement is substantial and sustained 4, 5:

  • Pain reduction: Visual analog scale scores improve from mean 69.5 preoperatively to 11 postoperatively at 3.8-year follow-up 4
  • Functional improvement: Lysholm scores increase from 73.7 to 86.1 4
  • Structural fill: 93% defect fill with good-quality cartilage at second-look arthroscopy 3

Critical Caveats

Athletic patients face specific limitations 5. While 70% achieve good clinical and functional improvement, 80% show decline in sports participation over time at final follow-up, suggesting microfracture may not be definitive for high-level athletes and future procedures may be needed 5.

Avoid stem cell injections as the American College of Rheumatology/Arthritis Foundation does not recommend them due to heterogeneity and lack of standardization 1, 2.

Long-term monitoring is mandatory as chondromalacia may progress to osteoarthritis if not properly managed 1.

Adjunctive Conservative Management

While conservative treatment serves primarily as a temporizing measure and does not address the underlying cartilage defect 1, consider:

  • First-line analgesia: Paracetamol (acetaminophen), though efficacy is uncertain and likely small 1
  • Second-line analgesia: NSAIDs when paracetamol insufficient, but recognize long-term gastrointestinal and cardiovascular risks 1
  • Bracing: Patellofemoral braces for significant impact on ambulation, joint stability, or pain 1

References

Guideline

Chondromalacia Patella Classification and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment Options for Full Thickness Cartilage Defects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of full thickness chondral lesions of the knee with microfracture in a group of athletes.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.